Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats
- 1 January 2002
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 24 (1) , 39-45
Abstract
Purpose. To evaluate the efficacy and safety of a new systemic formulation of cyclosporin A (CsA)-loaded microspheres in a rat model of penetrating keratoplasty rejection. Methods. Female Lewis rat...Keywords
This publication has 10 references indexed in Scilit:
- Systemic cyclosporin treatment for high-risk corneal transplantationOcular Immunology and Inflammation, 1996
- Systemic cyclosporine in high-risk keratoplasty: Long-term resultsEye, 1995
- Kinetics of Corneal Transplant Rejection in the Rat Penetrating Keratoplasty ModelCornea, 1994
- Systemic Cyclosporine in High-risk KeratoplastyOphthalmology, 1994
- Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin AInternational Journal of Pharmaceutics, 1993
- Pharmacokinetics of two Alternative Dosage Forms for Cyclosporine: Liposomes and IntralipidJournal of Pharmaceutical Sciences, 1990
- Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheresJournal of Microencapsulation, 1989
- Cyclosporine inhibits macrophage-mediated antigen presentation.The Journal of Immunology, 1986
- CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: ONE-YEAR FOLLOW-UP OF A MULTICENTRE TRIALThe Lancet, 1983
- Liquid-chromatographic determination of cyclosporin A in blood and plasma.Clinical Chemistry, 1981